Search Results 61-70 of 9232 for Mediate

  1. Teerin Liewluck, M.D. - Mayo Clinic Faculty Profiles

    Immune-mediated myopathies encompass a group of autoimmune muscle diseases, including those with inflammation observed on muscle biopsy: inflammatory myopathies ...

  2. Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration - Mayo Clinic Research

    Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration. Lay summary. Hepatocellular carcinoma (HCC) ...

  3. A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Patients With Kidney Transplant - Mayo Clinic

    To evaluate the efficacy of Cinryze® given for the treatment of acute antibody-mediated rejection (of renal allograft) (AMR) in kidney transplant recipients as ...

  4. ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) (ConTTRibute) - Mayo Clinic

    ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) (ConTTRibute). Print details. Share ...

  5. Tumor Invasion and Metastasis - Department of Cancer Biology - Mayo Clinic Research

    D., is defining how signaling pathways converge to mediate cancer cell invasion, cell growth and cell survival in order to identify novel targets that can serve ...

  6. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

    Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) ...

  7. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis · Overview · Participation ...

  8. Meditation: A simple, fast way to reduce stress - Mayo Clinic

    Qigong. This practice most often combines meditation, relaxation, movement and breathing exercises to restore and maintain balance. Qigong (CHEE-gung) is part ...

  9. Understanding the role of proteolytic activity in mediating irritable bowel syndrome symptoms and disruption of intestinal barrier function - Mayo Clinic

    Understanding the role of proteolytic activity in mediating irritable bowel syndrome symptoms and disruption of intestinal barrier function. April 18, 2020.

  10. The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) - Mayo Clinic

    The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been ...